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China and the world of nephrology lost one of their most distinguished clinicians and physician-scientists on 16 March 2010. Dr. Lei-Shi Li passed 
away in Nanjing, China, at the age of 84. He was 
chair of the Research Institute of Nephrology, 
Jinling Hospital, Nanjing University School of 
Medicine, Nanjing, China. He was a clinician, 
physician-scientist, and educator, full of human-
ity, energy, and ideas. He lived through a dra-
matic period in China’s history and participated 
in a major way in the growth of nephrology as a 
specialty not only in China but also throughout 
the world. His legacy of science, clinical care, 
leadership, and education will remain a testi-
mony to his uniqueness.
Dr. Li was born in 1926 in Changsha City, 
Hunan Province, China. After graduating in 1949 
from the National Zhong Zheng Medical College 
in Nanjing, he interned from 1948 to 1949 at the 
National Central Hospital in Nanjing (now called 
Jinling Hospital), the largest medical center and 
university hospital administered directly under 
the Ministry of Health of the Chinese National-
ist government. After that, he remained at the 
National Central Hospital to receive three more 
years of residency training, after which he dedi-
cated himself to tropical medicine. During the 
ten years of the Cultural Revolution, he had to 
discontinue all his work. During this difficult 
period of political turmoil, he never surrendered 
his compassion for his patients, his faithfulness 
to the mission, his core values as a physician, 
or his commitment to society. In 1975, he was 
reinstated in his former post in Jinling Hospital. 
In 1978, he separated kidney disease from gen-
eral medicine as a new clinical discipline, and 
founded the Research Institute of Nephrology 
at Jinling Hospital, launching the era of modern 
nephrology in China. He was one of the found-
ers of the Chinese Society of Nephrology and 
was its vice president for ten years (1980–1990). 
He was the first nephrologist to be elected to the 
Chinese Academy of Science and Engineering 
(1994). As a pioneer, he started the training pro-
gram of nephrology at Jinling Hospital. As a key 
mentor, he edited the Primer on Kidney Disease 
in China, created a practical approach to per-
cutaneous renal biopsy, published a diagnostic 
atlas of renal pathology, introduced peritoneal 
dialysis into clinical practice, and established 
hemodialysis under very difficult conditions 
using simple and crude machines. He integrated 
kidney transplantation into clinical renal prac-
tice, and the Institute started kidney transplan-
tation in 1993. He trained the first generation of 
nephrologists in China. Hundreds of trainees 
and fellows trained, inspired, and nurtured by 
Dr. Li have devoted themselves to renal prac-
tice and research, not only in China but also 
around the world, and many are today’s leaders 
of nephrology in China.
It is impossible to fully describe Dr. Li’s 
many contributions, which established him as 
a foremost pioneer in investigative and clini-
cal nephrology. It was Lei-Shi Li who first used 
the Chinese herb Tripterygium wilfordii to treat 
patients with glomerular disease in the late 
1970s. Following his original description, numer-
ous studies have explored the potent immuno-
suppressive and anti-inflammatory properties 
of this drug, which is now used extensively in 
the treatment of glomerulonephritis and lupus 
nephritis and in organ transplantation. It was he 
who used rhubarb to treat chronic renal failure. 
He was first to introduce mycophenolate mofetil 
(MMF) for the treatment of lupus nephritis, as 
well as innovative multiple-target therapy (ster-
oid in combination with MMF and tacrolimus) 
for patients with lupus nephritis. Moreover, it 
was he who introduced and developed the tech-
nique of continuous blood purification in China. 
He was honored with China’s National Science 
and Technology Progress Award six times and 
was recognized as one of the top 100 doctors in 
China. He published 13 books, including the 
major textbook of nephrology in Chinese, and 
over 700 papers. He was the founder and, from 
1992, the editor in chief of the Chinese Journal of 
Nephrology, Dialysis and Transplantation, which 
has become one of the leading nephrology jour-
nals in China. Under his tireless and inspired 
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leadership, the Research Institute of Nephrol-
ogy has carried out cutting-edge research and 
developed many novel therapies for patients with 
renal disease. It is one of the leading clinical and 
research centers in the world devoted to the study 
of the kidney.
Lei-Shi Li was central not only in developing 
nephrology as a modern clinical discipline in 
China, but also in encouraging the interaction 
of the Chinese nephrology community with the 
international renal world. He was one of the key 
founders of the Asian Pacific Society of Nephrol-
ogy, and a council member (1985–1990). He was 
the first Chinese Councilor of the International 
Society of Nephrology (ISN) (1990–1997) and 
became an honorary member of the ISN. He 
was a member of the organizing committee of 
an international conference on continuous renal 
replacement therapies organized by Dr. Ravindra 
L. Mehta, and Honorary Fellow of the Hong Kong 
College of Physicians. He transcended national 
boundaries and political disparities to bring 
China into the larger global community and, 
more importantly, to bring many international 
leaders of nephrology and medicine to China. 
In 1983 Dr. Li organized the first visit of Western 
nephrologists (Drs. Schrier, Becker, and Atkins) 
to lecture at multiple renal centers throughout 
China. After a breakthrough in hosting an Inter-
national Workshop of Renal Disease in Nanjing 
in 1988, with great courage, he successfully 
organized and chaired the 4th Conference of the 
Asian Pacific Society of Nephrology in 1990 in 
Beijing. This meeting has been recognized as a 
symbol of the exposure of the Chinese Society of 
Nephrology to the international renal commu-
nity. Many leaders in international nephrol ogy 
still vividly remember the stimulating scientific 
activities in the international symposium on 
diabetic nephropathy in Nanjing in 1993, and 
the conference hall crowded with participants 
of the ISN continuing medical education course 
in Nanjing in 1997. Dr. Li fostered a very active 
and successful ISN Sister Renal Center program 
together with Dr. Lance Dworkin between the 
Research Institute of Nephrology of Jinling Hos-
pital and the Division of Kidney Diseases and 
Hypertension at the Alpert Medical School of 
Brown University. For more than ten years, these 
two institutions have exchanged faculty, trained 
a large number of clinicians and physician-sci-
entists, jointly hosted international conferences, 
and conducted collaborative clinical and bench 
research. In recognition of his important contri-
butions to academic medicine at Brown, Lei-Shi 
Li was appointed Adjunct Professor of Medicine 
at Brown University. Since 2003, he annually 
organized a continuing medical education meet-
ing called Forefronts in Glomerular Disease—
Nanjing Forum, which has been endorsed as an 
ISN Commission for the Global Advancement of 
Nephrology program and has become an impor-
tant event for international nephrology.
Lei-Shi Li was a man of culture, wisdom, and 
true humanitarianism, understanding Western 
philosophy and mastering traditional Chinese 
values. His contribution and achievements 
affected the lives of millions of people in China, 
as well as around the world. He was respected by 
his colleagues and friends, admired by all who 
worked with him, and beloved by his patients. He 
will be sorely missed. The Research Institute of 
Nephrology at Jinling Hospital in Nanjing, China, 
the real legacy of Dr. Lei-Shi Li, will extend his 
distinguished influence far beyond professional 
scientific circles.
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